
Genomic Test Spares Breast Cancer Patients from Chemo
A breakthrough genomic test could help millions of breast cancer patients avoid unnecessary chemotherapy while maintaining excellent outcomes. The innovation promises to transform treatment decisions for early-stage breast cancer worldwide.

















